The article analyzes the experience of palliative treatment of 68 patients with dysphagia due to esophageal obstruction. In 61 patients, stenting was performed as planned, and 7 patients were operated on for emergency indications due to progressive dysphagia of the III-VI degree with damage to the upper 5 (7.3%) patients, the middle 24 (35.29 %) patients and the lower third of the esophagus of 39 (57.3 %) patients. Among them, esophageal tracheal and esophageal bronchial fistulas were detected in 28 patients with esophageal cancer. In 9 (32.14 %) patients, a fistula appeared after radiation therapy on the area of the primary tumor, in 19 (67.85 %) it was the result of the collapse of the primary tumor. According to our study of patients with esophageal cancer with dysphagia, men were 43 (63.2%), and women – 25 (36.7%), the average age was 65-85 years. Of the 68 patients with esophageal cancer with dysphagia, the urban population was 23 (33.82 %) patients and the rural population was 45 (66.17 %) patients.
All patients were recanalized and self-expanding stents with a company coating (FLEXTENT) were installed.
The study of morphological variants of the tumor showed: that 39 (57.35%) patients had adenocarcinoma and 29 (42.640%) squamous cell carcinoma.
Based on our analysis, endoscopic stenting should be recognized as the leading method of palliative treatment of patients with esophageal cancer complicated by dysphagia.